Xr Securities LLC Moderna, Inc. Call Options Transaction History

Xr Securities LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 08, 2024	SELL	$85.37 - $115.44 $264,647 - $357,864	-3,100 Reduced 44.93%	3,800 $404,000
Q4 2023 Feb 02, 2024	BUY	$69.51 - $104.43 $145,971 - $219,303	2,100 Added 43.75%	6,900 $686,000
Q3 2023 Oct 26, 2023	SELL	$96.41 - $126.61 $260,307 - $341,847	-2,700 Reduced 36.0%	4,800 $495,000
Q2 2023 Aug 08, 2023	BUY	$118.5 - $160.53 $331,800 - $449,484	2,800 Added 59.57%	7,500 $911,000
Q1 2023 May 02, 2023	SELL	$135.66 - $197.02 $664,734 - $965,398	-4,900 Reduced 51.04%	4,700 $721,000
Q4 2022 Jan 23, 2023	BUY	$118.38 - $210.04 $1.14 Million - $2.02 Million	9,600 New	9,600 $0
Q4 2021 Jan 10, 2022	BUY	$225.82 - $368.51 $2.94 Million - $4.79 Million	13,000 Added 58.56%	35,200 $627,000
Q3 2021 Oct 14, 2021	BUY	$221.9 - $484.47 $3.02 Million - $6.59 Million	13,600 Added 158.14%	22,200 $1.49 Million
Q2 2021 Jul 26, 2021	SELL	$129.91 - $234.98 $467,676 - $845,928	-3,600 Reduced 29.51%	8,600 $678,000
Q1 2021 Apr 29, 2021	SELL	$109.18 - $185.98 $1.39 Million - $2.36 Million	-12,700 Reduced 51.0%	12,200 $138,000
Q4 2020 Jan 13, 2021	BUY	$65.74 - $169.86 $1.64 Million - $4.23 Million	24,900 New	24,900 $378,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.